Entera Bio Ltd.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 25, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Sep 23, 2026 | LifeSci Capital | initiate | — → Outperform | — | 57% |
| Sep 22, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Sep 18, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Apr 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 2, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Dec 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 8, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Apr 4, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Mar 28, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Sep 6, 2022 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Jul 19, 2022 | B. Riley Securities | maintain | — → Buy | $5 | 54% |
| Jun 16, 2021 | B. Riley Securities | initiate | — → Buy | $9 | 54% |
| Mar 22, 2021 | Aegis Capital | initiate | — → Buy | $12 | — |
| Aug 3, 2018 | Maxim Group | initiate | — → Buy | $12 | 41% |
No cross-platform signals in the last 90 days